Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.59
-0.63 (-3.28%)
At close: Mar 6, 2026, 4:00 PM EST
18.60
+0.01 (0.05%)
After-hours: Mar 6, 2026, 6:16 PM EST
Caris Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 812.03 | 412.26 | 306.13 | 258.49 |
| Revenue Growth (YoY) | 96.97% | 34.67% | 18.43% | - |
| Cost of Revenue | 271 | 231.83 | 214.87 | 178.46 |
| Gross Profit | 541.04 | 180.43 | 91.26 | 80.02 |
| Selling, General & Admin | 396.37 | 326.05 | 296.04 | 294.51 |
| Research & Development | 99.56 | 111.5 | 114.77 | 101.27 |
| Operating Expenses | 495.93 | 437.55 | 410.81 | 395.78 |
| Operating Income | 45.11 | -257.12 | -319.55 | -315.76 |
| Interest Expense | -56.85 | -50.03 | -31.61 | -26.68 |
| Interest & Investment Income | 16.5 | 7.12 | 11.26 | 0.95 |
| Other Non Operating Income (Expenses) | -52.95 | 18.14 | 9.4 | 20.66 |
| EBT Excluding Unusual Items | -48.19 | -281.89 | -330.5 | -320.83 |
| Other Unusual Items | -19.9 | - | -10.92 | - |
| Pretax Income | -68.09 | -281.89 | -341.42 | -320.83 |
| Net Income | -68.09 | -281.89 | -341.42 | -320.83 |
| Preferred Dividends & Other Adjustments | 469.87 | 96.37 | 121.11 | 79 |
| Net Income to Common | -537.96 | -378.26 | -462.53 | -399.83 |
| Shares Outstanding (Basic) | 167 | 35 | 35 | 33 |
| Shares Outstanding (Diluted) | 167 | 35 | 35 | 33 |
| Shares Change (YoY) | 371.04% | 1.59% | 4.73% | - |
| EPS (Basic) | -3.22 | -10.66 | -13.24 | -11.98 |
| EPS (Diluted) | -3.22 | -10.66 | -13.24 | -11.98 |
| Free Cash Flow | 66.9 | -253.64 | -298.42 | -327.96 |
| Free Cash Flow Per Share | 0.40 | -7.15 | -8.54 | -9.83 |
| Gross Margin | 66.63% | 43.77% | 29.81% | 30.96% |
| Operating Margin | 5.56% | -62.37% | -104.38% | -122.16% |
| Profit Margin | -66.25% | -91.75% | -151.09% | -154.68% |
| Free Cash Flow Margin | 8.24% | -61.52% | -97.48% | -126.88% |
| EBITDA | 67.73 | -208.21 | -270.55 | -267.5 |
| EBITDA Margin | 8.34% | -50.50% | -88.38% | -103.49% |
| D&A For EBITDA | 22.62 | 48.91 | 49 | 48.25 |
| EBIT | 45.11 | -257.12 | -319.55 | -315.76 |
| EBIT Margin | 5.56% | -62.37% | -104.38% | -122.16% |
| Revenue as Reported | 812.03 | 412.26 | 306.13 | 258.49 |
| Advertising Expenses | 3.6 | 1.2 | 0.6 | 1 |
Source: S&P Capital IQ. Standard template.
Financial Sources.